Re: Aboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al. Performance of [89 Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.003.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.